
Priscilla Lynch
Journalist and Editor at Freelance
Clinical Editor at The Medical Independent
Award winning journalist & editor, specialising in health & medical science news. Clinical Editor @med_indonews, freelancer, @medscapeUK writer, & @icfj Fellow
Articles
-
3 days ago |
medscape.com | Priscilla Lynch
Mental health inpatient services in England continue to ignore critical safety recommendations, putting patients and staff at risk, according to a new report. The Health Services Safety Investigations Body (HSSIB) based its findings on multiple investigations into inpatient mental health care between September 2024 and January 2025. The report highlighted persistent systemic failures that have persisted despite previous warnings.
-
1 month ago |
medicalindependent.ie | Priscilla Lynch
-
1 month ago |
medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Simon Bull |Priscilla Lynch
Reference: April 2025 | Issue 4 | Vol 11 | Page 36 Beaumont RCSI Cancer Centre and the Irish Cancer Society has launched a first-of-its-kind pilot initiative for earlier diagnosis of lung cancer. Lung Health Check will provide lung screening in the community for individuals between 55 and 74 years of age at high risk of lung cancer.
-
1 month ago |
medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Simon Bull |Priscilla Lynch
Reference: April 2025 | Issue 4 | Vol 11 | Page 42 Research led by the Centre for Experimental Pathogen Host Research (CEPHR) at University College Dublin has found that memory B cells are a more accurate indication of Covid-19 vaccine protection than antibody titres or T-cell responses. A clear immune correlate of protection from SARS-CoV-2 infection has been lacking.
-
1 month ago |
medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Priscilla Lynch |J Whooley
Reference: April 2025 | Issue 4 | Vol 11 | Page 41 Pembrolizumab monotherapy is an established front-line treatment for advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) tumour proportion score (TPS) ≥50 per cent. However, real-world data on its long-term efficacy remain sparse.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 9K
- Tweets
- 22K
- DMs Open
- No

The CEO of the HSE Bernard Gloster has today confirmed that he will step down from the role at the beginning of next March. He will retire from the public service at that time having served almost 38 years in the public health service, including three of those as CEO of the HSE.

RT @TheHPRA: In 2024, we detained a higher number of illegal GLP-1 products than in 2022 and 2023. GLP-1 products are prescription medici…

My op ed in this weekend's Irish Times: Spinal surgeries report - At heart of health service issues is a labyrinthine and confusing system of governance and care https://t.co/whENk0thWw